|
Market Closed -
Nasdaq
00:00:00 17/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 533.12 USD | -1.55% |
|
-2.92% | +9.41% |
| 10-17 | United Therapeutics Insider Sold Shares Worth $4,517,709, According to a Recent SEC Filing | MT |
| 10-15 | Liquidia surges after agreement ending litigation with United Therapeutics |  |
| Market Cap | 22.87B 20.33B 18.84B 17.14B 32.34B 2,170B 32.86B 226B 88.79B 1,132B 85.82B 83.99B 3,610B | P/E 2026 * |
20.2x | P/E 2027 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 20.16B 17.92B 16.61B 15.11B 28.51B 1,913B 28.97B 200B 78.27B 998B 75.65B 74.04B 3,183B | EV / Sales 2026 * |
6.32x | EV / Sales 2027 * | 5.27x |
| Free-Float |
53.72% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| UTHR | Delayed | |
CBOE
| UTHR | Real-time | |
|
Tradegate
| UTH | Real-time | |
|
Boerse Muenchen
| UTH | Real-time | |
|
Deutsche Boerse AG
| UTH | Delayed | |
|
Börse Stuttgart
| UTH | Delayed | |
|
Berne S.E.
| UTH | End-of-day quote |
Last Transcript: United Therapeutics Corporation
| 1 day | -1.55% | ||
| 1 week | -2.92% | ||
| Current month | -1.62% | ||
| 1 month | +7.21% | ||
| 3 months | -0.48% | ||
| 6 months | -9.39% | ||
| Current year | +9.41% |
| 1 week | 523.95 |  | 555.58 |
| 1 month | 468.97 | | 585.79 |
| Current year | 455.63 | | 609.35 |
| 1 year | 409.07 | | 609.35 |
| 3 years | 208.62 | | 609.35 |
| 5 years | 158.38 | | 609.35 |
| 10 years | 74.31 | | 609.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 26/06/1996 | |
| President | 54 | 26/06/2016 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 13/03/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 01/01/2002 |
| Chairman | 71 | 26/06/1996 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 01/01/2002 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/10/26 | Exercice | Chief Executive Officer | 28,500 | 0.0664% | ||
| 13/10/26 | Exercice | Chief Executive Officer | 28,500 | 0.0664% | ||
| 12/10/26 | Exercice | Chief Executive Officer | 28,500 | 0.0664% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.55% | -2.92% | +23.03% | +125.16% | 22.87B | |
| +0.43% | +6.59% | +56.57% | +106.64% | 1,120B | |
| +0.90% | -2.25% | +32.26% | +63.73% | 616B | |
| +0.71% | +3.24% | +24.33% | +91.33% | 504B | |
| -0.13% | +5.98% | +33.66% | +50.18% | 367B | |
| +0.52% | +0.24% | +72.13% | +40.11% | 360B | |
| -0.95% | +4.70% | +19.65% | +42.71% | 288B | |
| -1.98% | +3.73% | -0.89% | +10.43% | 258B | |
| -0.35% | +4.25% | +44.74% | +52.06% | 234B | |
| -0.75% | +3.32% | +27.18% | +94.07% | 194B | |
| Average | -0.32% | +2.96% | +33.27% | +67.64% | 396.38B | |
| Weighted average by Cap. | +0.12% | +3.79% | +39.24% | +72.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.19B 2.83B 2.63B 2.39B 4.51B 303B 4.58B 31.57B 12.38B 158B 11.96B 11.71B 503B | 3.61B 3.21B 2.98B 2.71B 5.11B 343B 5.19B 35.78B 14.03B 179B 13.56B 13.27B 570B |
| Net income | 1.22B 1.08B 1B 911M 1.72B 115B 1.75B 12.04B 4.72B 60.2B 4.56B 4.46B 192B | 1.43B 1.27B 1.18B 1.07B 2.02B 136B 2.05B 14.15B 5.55B 70.78B 5.36B 5.25B 226B |
| Net Debt | -2.71B -2.41B -2.23B -2.03B -3.83B -257B -3.89B -26.82B -10.51B -134B -10.16B -9.95B -428B | -3.81B -3.39B -3.14B -2.86B -5.4B -362B -5.48B -37.77B -14.81B -189B -14.31B -14.01B -602B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | $533.12 | -1.55% | 668,250 |
| 15/10/26 | $541.51 | +0.27% | 545,400 |
| 14/10/26 | $540.03 | -0.62% | 883,182 |
| 13/10/26 | $543.40 | -1.22% | 538,230 |
| 12/10/26 | $550.10 | +0.17% | 840,641 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UTHR Stock
Select your edition
All financial news and data tailored to specific country editions
